脂肪酸通过维持SCML4表达来支持瘤 CD8+ T 细胞的健康和功能
Maoxiao Feng1,2, Xiaoyan Liu3, Xiaodong Hao1
1Department of Clinical Laboratory, The Second Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Cancer research
|August 23, 2023
概括
转录因子SCML4通过促进CD8+T细胞功能和存活来增强抗瘤免疫力. 由脂肪酸代谢驱动的SCML4的升级,改善了癌症预后,并提高了免疫治疗的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- CD8+ T细胞,包括组织内存T (Trm) 细胞和瘤透性淋巴细胞 (TILs),对于抗瘤免疫和免疫监测至关重要.
- 了解Trm细胞和TILs的调节机制,可以揭示增强抗癌免疫反应的策略.
研究的目的:
- 研究转录因子SCML4在CD8+Trm细胞和TILs的功能和调节中的作用.
- 阐明SCML4影响抗瘤免疫力的分子机制.
- 探索SCML4作为癌症免疫治疗的潜在治疗标.
主要方法:
- 对来自癌症患者和小鼠模型的CD8+T细胞中SCML4表达的分析.
- 在CD8+T细胞中对SCML4进行基因操纵,以评估其对瘤生长和T细胞功能的影响.
- 涉及蛋白质复合体招募和基因表达分析的机制研究.
- 研究调节SCML4表达的信号通路,包括脂肪酸代谢和mTOR信号.
- 评估SCML4对抗PD-1疗法的疗效的影响.
主要成果:
- SCML4对于Trm细胞和TIL细胞的进展和多功能性至关重要.
- 在CD8+T细胞中增加SCML4表达显著降低了小鼠的瘤生长.
- 删除SCML4会损害抗瘤免疫力,并促进CD8+ T细胞的消耗.
- SCML4招募HBO1-BRPF2-ING4复合体来调节T细胞特异性基因表达,增强T细胞存活率和效应器功能.
- 脂肪酸代谢,通过mTOR-IRF4-PRDM1信号传递,上调SCML4,促进组织居民和多功能基因表达.
- SCML4通过增加效应分子表达和抑制TIL亡来增强抗PD-1疗法的疗效.
结论:
- SCML4在维护CD8+Trm细胞和TILs的抗瘤功能方面发挥着至关重要的作用.
- 受脂肪酸代谢影响的SCML4介导途径代表了增强抗癌免疫力的新型免疫代谢轴.
- SCML4是改善癌症免疫治疗结果的有希望的治疗标.
相关概念视频
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:22T Cell Activation and Clonal Selection
806
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
806
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K